The patient¿s attorney alleged a deficiency against the device.
The product was used for therapeutic treatment of a ventral hernia.
It was reported that after implant, the patient experienced recurrence, adhesions, fistula, ulcerated hernia sac, inflammation, fibrosis, devascularized hernia sac.
, wound opening, wound dehiscence, small bowel evisceration, exposed intestine, gut failure, calcification, scar tissue, ulcers, and mesh erosion into viscera.
Post-operative patient treatment included mesh removal, hernia repair with new mesh, lysis of adhesions, evisceration, takedown/repair of gastrocutaneous fistula, repair of enterotomy of the colonic conduit, primary repair of enterotomy of the colon, excised skin/subcutaneous tissue, right/left myofascial advancement flap, closure of fascia, wound vac, primary skin closure, full-thickness biopsy of the deep abdominal wall ulcers, closure of abdomen in 2 layers, and cholecystectomy.
|